Literature DB >> 27225886

Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease.

Giovanni Luca1, Ilaria Bellezza1, Iva Arato1, Alba Di Pardo2, Francesca Mancuso1, Mario Calvitti1, Giulia Falabella1, Sara Bartoli1, Vittorio Maglione2, Enrico Amico2, Mariagrazia Favellato3, Giuseppe Basta4, Maria Bodo1, Alba Minelli1, Riccardo Calafiore4, Luigi Frati2, Ferdinando Squitieri5.   

Abstract

INTRODUCTION: Immune dysfunction, promoted by pro-inflammatory cytokines, plays a pivotal role in neurodegeneration associated with Huntington's disease. AIMS: The aim of this study was to investigate the emerging immunoregulatory and antiinflammatory properties of Sertoli cells in Huntington's disease.
METHODS: The experimental R6/2 mouse model of Huntington's disease was treated by a single intraperitoneal injection of microencapsulated prepubertal porcine Sertoli cells and lifespan, motor performance and striatal inflammatory pattern have been evaluated.
RESULTS: The results of this study demonstrated that a single intraperitoneal injection of microencapsulated prepubertal porcine Sertoli cells uniquely improved performances and extended the life expectancy of R6/2 Huntington's disease mice, by immune dysfunction modulation in brain.
CONCLUSIONS: This study highlights the immunomodulatory and trophic role of Sertoli cells that could be of help in the treatment of neurodegenerative disorders.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cell transplant; Inflammation; Microcapsules; Motor performance

Mesh:

Substances:

Year:  2016        PMID: 27225886      PMCID: PMC6492803          DOI: 10.1111/cns.12569

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  10 in total

1.  Neurodegenerative disease: 'fifty shades of grey' in the Huntington disease gene.

Authors:  Ferdinando Squitieri
Journal:  Nat Rev Neurol       Date:  2013-06-25       Impact factor: 42.937

2.  Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy.

Authors:  Giovanni Luca; Francesca Mancuso; Mario Calvitti; Iva Arato; Giulia Falabella; Antonello Bufalari; Valentina De Monte; Enrico Tresoldi; Claudio Nastruzzi; Giuseppe Basta; Francesca Fallarino; Cinzia Lilli; Catia Bellucci; Tiziano Baroni; Maria Chiara Aglietti; Stefano Giovagnoli; Don F Cameron; Maria Bodo; Riccardo Calafiore
Journal:  Xenotransplantation       Date:  2015-07-02       Impact factor: 3.907

3.  Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.

Authors:  Janelle Drouin-Ouellet; Stephen J Sawiak; Giulia Cisbani; Marie Lagacé; Wei-Li Kuan; Martine Saint-Pierre; Richard J Dury; Wael Alata; Isabelle St-Amour; Sarah L Mason; Frédéric Calon; Steve Lacroix; Penny A Gowland; Susan T Francis; Roger A Barker; Francesca Cicchetti
Journal:  Ann Neurol       Date:  2015-04-09       Impact factor: 10.422

4.  Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study.

Authors:  Alba I Rodriguez; Alison E Willing; Samuel Saporta; Don F Cameron; Paul R Sanberg
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

5.  Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity.

Authors:  Ilaria Bellezza; Silvia Grottelli; Anna Lisa Mierla; Ivana Cacciatore; Erika Fornasari; Luca Roscini; Gianluigi Cardinali; Alba Minelli
Journal:  Int J Biochem Cell Biol       Date:  2014-03-31       Impact factor: 5.085

6.  Structural and functional features of central nervous system lymphatic vessels.

Authors:  Antoine Louveau; Igor Smirnov; Timothy J Keyes; Jacob D Eccles; Sherin J Rouhani; J David Peske; Noel C Derecki; David Castle; James W Mandell; Kevin S Lee; Tajie H Harris; Jonathan Kipnis
Journal:  Nature       Date:  2015-06-01       Impact factor: 49.962

Review 7.  The role of the immune system in Huntington's disease.

Authors:  Gisa Ellrichmann; Christiane Reick; Carsten Saft; Ralf A Linker
Journal:  Clin Dev Immunol       Date:  2013-07-15

8.  Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.

Authors:  Francesca Fallarino; Giovanni Luca; Mario Calvitti; Francesca Mancuso; Claudio Nastruzzi; Maria C Fioretti; Ursula Grohmann; Ennio Becchetti; Anne Burgevin; Roland Kratzer; Peter van Endert; Louis Boon; Paolo Puccetti; Riccardo Calafiore
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

9.  FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.

Authors:  Alba Di Pardo; Enrico Amico; Mariagrazia Favellato; Roberta Castrataro; Sergio Fucile; Ferdinando Squitieri; Vittorio Maglione
Journal:  Hum Mol Genet       Date:  2013-12-02       Impact factor: 6.150

Review 10.  The mechanism of degeneration of striatal neuronal subtypes in Huntington disease.

Authors:  Azadeh A Rikani; Zia Choudhry; Adnan M Choudhry; Nasir Rizvi; Huma Ikram; Nusrat J Mobassarah; Sagun Tulli
Journal:  Ann Neurosci       Date:  2014-07
  10 in total
  9 in total

Review 1.  Sertoli Cell Immune Regulation: A Double-Edged Sword.

Authors:  Rachel L Washburn; Taylor Hibler; Gurvinder Kaur; Jannette M Dufour
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

2.  Therapeutic Potential of Pretreatment with Allograft Sertoli Cells Transplantation in Brain Ischemia by Improving Oxidative Defenses.

Authors:  Sara Milanizadeh; Karrar Najm Najaf Zuwarali; Abbas Aliaghaei; Mohammad Reza Bigdeli
Journal:  J Mol Neurosci       Date:  2018-03-17       Impact factor: 3.444

3.  "In vitro" Effect of Different Follicle-Stimulating Hormone Preparations on Sertoli Cells: Toward a Personalized Treatment for Male Infertility.

Authors:  Iva Arato; Giuseppe Grande; Ferran Barrachina; Catia Bellucci; Cinzia Lilli; Meritxell Jodar; Maria Chiara Aglietti; Francesca Mancini; Federica Vincenzoni; Alfredo Pontecorvi; Riccardo Calafiore; Rafael Oliva; Giovanni Luca; Francesca Mancuso; Domenico Milardi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-18       Impact factor: 5.555

Review 4.  Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy?

Authors:  Sara Chiappalupi; Laura Salvadori; Giovanni Luca; Francesca Riuzzi; Riccardo Calafiore; Rosario Donato; Guglielmo Sorci
Journal:  Cell Prolif       Date:  2019-03-26       Impact factor: 6.831

5.  In "Vitro" Lps-Stimulated Sertoli Cells Pre-Loaded With Microparticles: Intracellular Activation Pathways.

Authors:  Iva Arato; Domenico Milardi; Stefano Giovagnoli; Giuseppe Grande; Catia Bellucci; Cinzia Lilli; Sara Bartoli; Sara Corneli; Piera Mazzone; Mario Calvitti; Tiziano Baroni; Riccardo Calafiore; Francesca Mancuso; Giovanni Luca
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-07       Impact factor: 5.555

6.  Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts.

Authors:  Laura Salvadori; Sara Chiappalupi; Iva Arato; Francesca Mancuso; Mario Calvitti; Maria Cristina Marchetti; Francesca Riuzzi; Riccardo Calafiore; Giovanni Luca; Guglielmo Sorci
Journal:  Biomolecules       Date:  2021-10-12

7.  Melatonin modulates Nrf2 activity to protect porcine pre-pubertal Sertoli cells from the abnormal H2 O2 generation and reductive stress effects of cadmium.

Authors:  Desirée Bartolini; Iva Arato; Francesca Mancuso; Daniela Giustarini; Catia Bellucci; Carmine Vacca; Maria Chiara Aglietti; Anna Maria Stabile; Ranieri Rossi; Gabriele Cruciani; Mario Rende; Riccardo Calafiore; Giovanni Luca; Francesco Galli
Journal:  J Pineal Res       Date:  2022-05-24       Impact factor: 12.081

8.  Effect of EPA on Neonatal Pig Sertoli Cells "In Vitro": A Possible Treatment to Help Maintain Fertility in Pre-Pubertal Boys Undergoing Treatment With Gonado-Toxic Therapies.

Authors:  Iva Arato; Veronica Ceccarelli; Francesca Mancuso; Catia Bellucci; Cinzia Lilli; Piero Ferolla; Katia Perruccio; Alessandro D'Arpino; Maria Chiara Aglietti; Riccardo Calafiore; Don F Cameron; Mario Calvitti; Tiziano Baroni; Alba Vecchini; Giovanni Luca
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-20       Impact factor: 5.555

9.  Allograft of Sertoli Cell Transplantation in Combination with Memantine Alleviates Ischemia-Induced Tissue Damages in An Animal Model of Rat.

Authors:  Zeinab SafialHosseini; Mohammadreza Bigdeli; Sepideh Khaksar; Abbas Aliaghaei
Journal:  Cell J       Date:  2019-12-15       Impact factor: 2.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.